Martin Zentgraf has 35 years of leadership in the pharma and medtech industry, including 6 years as a chairman at BPI and over 10 years as a board member of the Federal Association of the Pharmaceutical Industry.
Martin began his career at Byk Gulden (now Takeda) as a Product Manager and was responsible for various successful licensing projects and launches. Most recently, he worked as an independent consultant with expertise in pharmaceuticals and medical devices. His professional experience also includes a variety of leadership positions within the healthcare industry.
Martin received a MD from the University of Münster and earned his Doctor title shortly after. Martin is also fluent in German, Spanish, and English.